Loncar China Biopharma ETF (NASDAQ:CHNA) Shares Down 2.5%

Loncar China Biopharma ETF (NASDAQ:CHNA – Get Rating)’s stock price dropped 2.5% during mid-day trading on Wednesday . The stock traded as low as $16.84 and last traded at $16.84. Approximately 218 shares were traded during trading, a decline of 64% from the average daily volume of 600 shares. The stock had previously closed at $17.27.

Loncar China Biopharma ETF Price Performance

The business has a 50-day simple moving average of $17.82 and a 200 day simple moving average of $18.44.

Hedge Funds Weigh In On Loncar China Biopharma ETF

A hedge fund recently bought a new stake in Loncar China Biopharma ETF stock. OLD Mission Capital LLC bought a new position in Loncar China Biopharma ETF (NASDAQ:CHNA – Get Rating) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 4,620 shares of the company’s stock, valued at approximately $87,000. OLD Mission Capital LLC owned approximately 1.54% of Loncar China Biopharma ETF as of its most recent filing with the Securities & Exchange Commission.

Loncar China Biopharma ETF Company Profile

(Get Rating)

The Loncar China BioPharma ETF (CHNA) is an exchange-traded fund that is based on the Loncar China BioPharma index. The fund tracks a tier-weighted index of companies directly involved in the growth of Chinas pharmaceutical and biotech industry. CHNA was launched on Aug 14, 2018 and is managed by Loncar.